Cardiovascular Advances in Research and Opportunities Legacy Act

United States117th CongressHR-1193House of Representatives
Updated: Dec 20, 2022

Summary

Cardiovascular Advances in Research and Opportunities Legacy Act This act addresses research, education, and awareness concerning valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health may conduct or support research on the disease in consultation with the National Heart, Lung, and Blood Institute (NHLBI). The NHLBI must also conduct a workshop on mitral valve prolapse, which occurs when the valve between the chambers of the left side of the heart seals improperly. The Department of Health and Human Services (HHS) must develop best practices to treat valvular heart disease. HHS may also carry out other projects to increase education and awareness of the disease.

Bill texts

Available versions
View official text

3 versions available

Timeline

Latest companion bill action

S-1133: Cardiovascular Advances in Research and Opportunities Legacy Act

Introduced in Senate

  1. Motion to reconsider laid on the table Agreed to without objection.

    House of Representatives

  2. Presented to President.

    House of Representatives

  3. Became Public Law No: 117-244.

  4. Signed by President.